MedDataX Logo

Observational Study of Meloxicam in Any Labeled Indication

NCT ID: NCT02182739

Last Updated: 2014-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

13039 participants

Study Classification

OBSERVATIONAL

Study Start Date

2001-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases

NCT02184039

Osteoarthritis
COMPLETED

Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions

NCT02184052

Arthritis, Rheumatoid
COMPLETED

Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome

NCT02180516

Arthritis, Rheumatoid
COMPLETED

Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

NCT02183129

Osteoarthritis
COMPLETED PHASE4

A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee

NCT02183116

Osteoarthritis
COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthritis, Rheumatoid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Meloxicam

Meloxicam

Intervention Type DRUG

tablets or injectable solution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Meloxicam

tablets or injectable solution

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients according to the physicians medical criteria on the labeled indications for Meloxicam

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

107.249

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis
NCT02183064 COMPLETED PHASE3
Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects
NCT02183077 COMPLETED PHASE1
A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
NCT00239395 COMPLETED PHASE3
Postmarketing Surveillance Study With MOBEC®
NCT02182726 COMPLETED
Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis
NCT02195492 COMPLETED
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
NCT02405793 WITHDRAWN PHASE2
Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip
NCT01801735 COMPLETED PHASE3
A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
NCT03936192 WITHDRAWN PHASE3
The Effect of ColcHicine on the Incidence of Knee or Hip Replacements
NCT06578182 RECRUITING PHASE3
Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life
NCT00619177 COMPLETED
Study of Meloxicam Capsules to Treat Osteoarthritis Pain
NCT01787188 COMPLETED PHASE3
Use of Synvisc® in Knee Osteoarthritis - Survey on Practice
NCT02195544 COMPLETED
Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee
NCT00819572 COMPLETED PHASE1/PHASE2
Treatment for Patients With Osteoarthritis (OA)
NCT00110942 COMPLETED PHASE2
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)
NCT00092781 COMPLETED PHASE3
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)
NCT00092742 COMPLETED PHASE3
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)
NCT00092703 COMPLETED PHASE3
Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain
NCT01451385 COMPLETED PHASE3
Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
NCT06863636 RECRUITING PHASE3
Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
NCT01111045 COMPLETED PHASE2
A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)
NCT00269191 COMPLETED PHASE3
The Pharmacokinetic Interaction Between Celecoxib and Rebamipide
NCT01549743 COMPLETED PHASE1
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 COMPLETED PHASE2
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.
NCT01233739 UNKNOWN PHASE4
A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee
NCT04675034 COMPLETED PHASE2